Subscribe

The Sukhjit Starch & Chemicals Limited (SUKHJITS.NS)

INR164.76 -6.30 (-3.68%)
IN NSE Basic Materials Chemicals - Specialty
Address Sarai Road 144401
Phagwara, IN
CEO Bhavdeep Sardana
Website sukhjitgroup.com
IPO 2022-11-07
ISIN INE450E01029

Explore sections of this company profile

Also trades on Bombay Stock Exchange · SUKHJITS.BO (INR) National Stock Exchange of India · SUKHJITS.NS (INR)
Description

Established in 1943 and headquartered in Phagwara, India, The Sukhjit Starch & Chemicals Limited is a prominent Indian manufacturer and supplier of starch and various derivatives. The company's business activities are structured into four distinct divisions: Starch & Its Derivatives, Readymade Garments, Leasing & Hire Purchase Financing, and the Manufacturing of Heavy Machinery. Among its comprehensive product offerings are maize starch, monohydrate dextrose, sorbitol, anhydrous dextrose, liquid glucose, high maltose syrup, malto dextrin powder, modified starch, maize gluten, maize germ, maize oil, and maize bran. These critical ingredients serve a wide array of sectors, including food processing, tobacco conditioning, injection formulations, paper production, pharmaceuticals, bread manufacturing, animal feed (for cattle, poultry, swine, and pets), and diverse industrial applications.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
INR164.76 -6.30 (-3.68%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
30.4K
Beta
0.33
Float Shares
10.14M
Free Float %
32.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.61% +3.47% +9.36% -8.16% +31.78% +7.13% -5.12% -4.75% -7.80% -7.80% -7.80%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
164.76
DCF (Unlevered) 251.90 +52.9%
DCF (Levered) 313.80 +90.5%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Quality scores
Altman Z-Score
2.46
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Chemicals - Specialty: +4.7%
    -4.4% Q1'26: +11.7% (vs Q1'25)
  • ✗
    EPS growth Chemicals - Specialty: +13.2%
    -32.4% Q1'26: +418.9% (vs Q1'25)
  • ✗
    FCF margin FCF growth · Chemicals - Specialty: +44.1%
    -2.7% Q1'26: -20.0% (vs Q1'25)
  • ✗
    EBIT margin Chemicals - Specialty: +8.8%
    +3.4% Q1'26: +4.6% (vs Q1'25)
  • ✗
    ROIC Chemicals - Specialty: +5.6%
    +4.5% Q1'26: +6.4% (vs Q1'25)
  • ✗
    Share dilution Chemicals - Specialty: +0.1%
    +0.0% Q1'26: 0.0% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    4.18× Q1'26: 4.65× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.37) × ERP
WACC = 64% × Ke + 36% × Kd (9.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 217.85 Current price: 164.76
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2017
actual 		Mar 2018
actual 		Mar 2019
actual 		Mar 2020
actual 		Mar 2021
actual 		Mar 2024
actual 		Mar 2025
actual 		Mar 2026
1 Rev. Ana.
1 EPS Ana. 		Mar 2027
1 Rev. Ana.
1 EPS Ana. 		Mar 2028
1 Rev. Ana.
1 EPS Ana. 		Mar 2029
1 Rev. Ana.
1 EPS Ana. 		Mar 2030
1 Rev. Ana.
1 EPS Ana. 		Mar 2031
1 Rev. Ana.
1 EPS Ana. 		Mar 2032
1 Rev. Ana.
1 EPS Ana. 		Mar 2033
1 Rev. Ana.
1 EPS Ana.
Revenue
6.54B
est: 6.48B (+0.9%)
7.01B
est: 7.11B (-1.4%)
7.41B
est: 7.37B (+0.6%)
7.99B
est: 8.00B (-0.1%)
6.99B
est: 8.80B (-20.6%)
13.75B
est: 14.30B (-3.8%)
14.98B
est: 15.50B (-3.4%)
6.48B
6.48B – 6.48B
-58.2% YoY
7.11B
7.11B – 7.11B
+9.8% YoY
7.37B
7.37B – 7.37B
+3.6% YoY
8.00B
8.00B – 8.00B
+8.6% YoY
8.80B
8.80B – 8.80B
+10.0% YoY
14.30B
14.30B – 14.30B
+62.5% YoY
15.50B
15.50B – 15.50B
+8.4% YoY
15.50B
15.50B – 15.50B
+0.0% YoY
EBITDA
521.55M
est: 681.28M (-23.4%)
690.72M
est: 747.71M (-7.6%)
932.23M
est: 774.43M (+20.4%)
598.35M
est: 841.20M (-28.9%)
727.26M
est: 925.32M (-21.4%)
1.38B
est: 1.50B (-8.4%)
1.20B
est: 1.63B (-26.4%)
681.28M
681.28M – 681.28M
-58.2% YoY
747.71M
747.71M – 747.71M
+9.8% YoY
774.43M
774.43M – 774.43M
+3.6% YoY
841.20M
841.20M – 841.20M
+8.6% YoY
925.32M
925.32M – 925.32M
+10.0% YoY
1.50B
1.50B – 1.50B
+62.5% YoY
1.63B
1.63B – 1.63B
+8.4% YoY
1.63B
1.63B – 1.63B
+0.0% YoY
EBIT
397.90M
est: 505.53M (-21.3%)
527.90M
est: 554.82M (-4.9%)
820.61M
est: 574.65M (+42.8%)
514.39M
est: 624.19M (-17.6%)
507.52M
est: 686.61M (-26.1%)
1.02B
est: 1.12B (-8.2%)
840.32M
est: 1.21B (-30.5%)
505.53M
505.53M – 505.53M
-58.2% YoY
554.82M
554.82M – 554.82M
+9.8% YoY
574.65M
574.65M – 574.65M
+3.6% YoY
624.19M
624.19M – 624.19M
+8.6% YoY
686.61M
686.61M – 686.61M
+10.0% YoY
1.12B
1.12B – 1.12B
+62.5% YoY
1.21B
1.21B – 1.21B
+8.4% YoY
1.21B
1.21B – 1.21B
+0.0% YoY
Net Income
179.95M
est: 308.93M (-41.7%)
226.70M
est: 243.94M (-7.1%)
411.84M
est: 425.00M (-3.1%)
331.31M
est: 570.20M (-41.9%)
209.08M
est: 647.53M (-67.7%)
499.62M
est: 633.63M (-21.1%)
399.51M
est: 803.60M (-50.3%)
308.93M
308.93M – 308.93M
-61.6% YoY
243.94M
243.94M – 243.94M
-21.0% YoY
425.00M
425.00M – 425.00M
+74.2% YoY
570.20M
570.20M – 570.20M
+34.2% YoY
647.53M
647.53M – 647.53M
+13.6% YoY
633.63M
633.63M – 633.63M
-2.1% YoY
803.60M
803.60M – 803.60M
+26.8% YoY
803.60M
803.60M – 803.60M
+0.0% YoY
SGA
167.88M
est: 260.03M (-35.4%)
246.67M
est: 285.38M (-13.6%)
281.05M
est: 295.58M (-4.9%)
260.66M
est: 321.06M (-18.8%)
283.84M
est: 353.17M (-19.6%)
496.38M
est: 573.82M (-13.5%)
516.75M
est: 621.97M (-16.9%)
260.03M
260.03M – 260.03M
-58.2% YoY
285.38M
285.38M – 285.38M
+9.8% YoY
295.58M
295.58M – 295.58M
+3.6% YoY
321.06M
321.06M – 321.06M
+8.6% YoY
353.17M
353.17M – 353.17M
+10.0% YoY
573.82M
573.82M – 573.82M
+62.5% YoY
621.97M
621.97M – 621.97M
+8.4% YoY
621.97M
621.97M – 621.97M
+0.0% YoY
EPS
12.44
est: 9.89 (+25.8%)
15.36
est: 7.81 (+96.7%)
27.90
est: 13.60 (+105.1%)
22.45
est: 18.25 (+23.0%)
7.09
est: 20.73 (-65.8%)
15.99
est: 20.28 (-21.2%)
12.79
est: 25.72 (-50.3%)
9.89
9.89 – 9.89
-61.6% YoY
7.81
7.81 – 7.81
-21.0% YoY
13.60
13.60 – 13.60
+74.2% YoY
18.25
18.25 – 18.25
+34.2% YoY
20.73
20.73 – 20.73
+13.6% YoY
20.28
20.28 – 20.28
-2.1% YoY
25.72
25.72 – 25.72
+26.8% YoY
25.72
25.72 – 25.72
+0.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-27 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-26 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-25 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-22 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-21 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-20 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-19 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-18 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-15 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-14 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-13 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-12 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-08 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-04 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-30 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-29 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-28 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-27 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-24 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-23 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-1.13B
OE per share TTM
-39.60
Owner's Yield
-18.21%
Maintenance CapEx ratio
565.99%
Maint CapEx / Avg PPE
45.7%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
382.0K
Shares Outstanding
31.24M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Kuldip Krishan Sardana MD & Executive Director 12M male
Madan Gopal Sharma Executive Director 2M male
Dhiraj Sardana Senior Vice President & Chief Executive Officer of New Project — male
Pankaj Sardana Senior Vice President of Operations - Nizamabad Unit — male
Puneet Sardana Senior Vice President of Operations - Malda Unit — male
Aman Setia Senior Vice President of Finance, Compliance Officer & Company Secretary — male
Rakesh Chawla Senior Vice President & Chief Financial Officer — male
Bhavdeep Sardana Senior Vice President & Chief Executive Officer of H.P Unit — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals - Specialty